Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects. Though, tumor inherent or acquired resistance to ICIs accompanied with treatment-related toxicities hamper their clinical utility. Overall, about 60–70% of patients (e.g., melanoma and lung cancer) who received ICIs show no objective response to intervention. The resistance to ICIs mainly caused by alterations in the tumor microenvironment (TME), which in turn, supports angiogenesis and also blocks immune cell antitumor activities, facilitating tumor cells' evasion from host immunosurveillance. Thereby, it has been supposed and also validated that combination therapy with ICIs and other therapeutic means, ranging from chemoradiotherapy to targeted therapies as well as cancer vaccines, can capably compromise tumor resistance to immune checkpoint blocked therapy. Herein, we have focused on the therapeutic benefits of ICIs as a groundbreaking approach in the context of tumor immunotherapy and also deliver an overview concerning the therapeutic influences of the addition of ICIs to other modalities to circumvent tumor resistance to ICIs.
Toxoplasmosis during pregnancy has an adverse effect on pregnant women, fetus and neonatal. The infection is generally asymptomatic but can cause severe effect on the fetus and immunocompromised women. Control study conducted on 77 pregnant women categorized according to the risk factors influencing toxoplasmosis infection. Specific anti Toxoplasma gondii IgG and IgM were evaluated using Enzyme-linked immunosorbent assay (ELISA) test kits. Among 77 pregnant women, (57.1%) women had toxoplasmosis, seropositive for latent infection with specific Toxoplasma gondii immunoglobulin G (IgG) antibodies were (54.54 %), whereas acute infection immunoglobulin M (IgM) were only in (2.59 %) cases. The seroprevalence of Toxoplasma was higher in older pregnant women (> 60%) than younger ones (<50%). The specific IgG antibody was higher in pregnant women working in farms (65.7 vs 45.23; P=0.053). Also, the seropositive IgG antibody was low in the first trimester and high in rural areas. Pregnant women need to educate more about toxoplasmosis and prevention to exposure in order to reduce the risk of congenital toxoplasmosis.
Foot and mouth disease virus (FMDV) is considered as one of highly contagious and economically devastating viral infection of cloven-hoofed animals in Iraq. This study was performed to investigate the molecular characterization and typing of the current outbreak of FMDV in Duhok province of Kurdistan- Iraq. A total of 15 epithelial samples were taken from clinically infected calves. These samples were subjected to RNA extraction and RT-PCR for the purpose of typing and detection as well as sequencing and phylogenetic analysis. All of 15 samples was positive for FMDV and detected as serotype O by multiplex RT-PCR. Furthermore, the sequences were shown a close relationship with Panasia topotype. The limitation of these monitoring studies is that the partial sequencing is not adequate to monitor the circulating strain as it might hide some important changes unsequenced, therefore the investigation of inclusion of complete gene of VP1 protein is highly recommended to get a complete picture of potential mutation on that immunogenic protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.